According to recent market projections, the Canadian weight loss market is expected to reach $4.03 billion by 2035, up from $1.18 billion in 2024. This surge is largely attributed to the increasing demand for effective and affordable weight loss solutions. One such solution is generic semaglutide, a medication that has been shown to have the same efficacy and safety profile as Ozempic and Wegovy.
Novo Nordisk’s failure to pay maintenance fees since 2018 has resulted in the loss of patent protection on these medications in Canada. This development has paved the way for companies like Hims & Hers Health to offer generic semaglutide drugs by 2026. The CEO, Andrew Dudum, sees this as an opportunity to provide affordable weight loss care to millions of Canadians struggling with their weight.
The statistics speak for themselves: one-third of Canadians are overweight or obese, and the prevalence is expected to continue rising unless effective interventions are implemented. With generic semaglutide offering a potential solution, it’s clear that the market is ripe for disruption. As the demand for weight loss solutions continues to grow, it will be interesting to see how the industry responds to this new development.
Crémieux
@cremieuxrecueil
·
Apr 21 Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound) are currently approved for weight loss in the U.S.
The next generation has yet to be approved, but it seems to work even better for total weight loss, even though it causes less muscle loss.
Crémieux
@cremieuxrecueil
·
Jun 24 It’s truly amazing just how low the gray market prices for GLP-1RA drugs are.
It’s trivial to get semaglutide for under $20 per month, or to get the far more effective GLP-1RA, retatrutide, for $40 per month.
I’ve linked a guide to doing that in the post below.
Crémieux
@cremieuxrecueil
·
Apr 30 I’ve just updated the source list in my article on how to get cheap Ozempic.
The currently noted source in the article sells Semaglutide for $15.36/month and Retatrutide for $43.20/month.
Remember: GLP-1 drugs are cheap!
Riyado Sofian
@riyadosofian
·
Jun 25 $NVO Wegovy is now back on the main page of $HIMS Weight Loss, now at a full price of $1,999/month.
In addition, it is placed 5th in line, as compared to being the 1st option a few days ago, before the deal termination.
Moreover, $HIMS Compounded GLP-1 is being marketed as
Maxima Mendez MD. FSIAC,FACC.
@MaximaMendez15
·
Jul 8 SURMOUNT-5 (NEJM 2025): Tirzepatide vs Semaglutide in Obesity
Tirzepatide led to:
−20.2% body weight (~−22.8 kg)
−18.4 cm waist
64.6% ≥15% weight loss (vs 40.1%)
31.6% ≥25% loss (vs 16.4%)
Outperformed semaglutide in all endpoints.
https://nej.md/44ZeMPz
Michael Albert, MD
@MichaelAlbertMD
·
May 12 Tirzepatide vs. Semaglutide
The heavyweight bout we’ve all been waiting for—and it’s a TKO.
– – –
A new NEJM study just dropped the first head-to-head trial in people with obesity (no diabetes).
Here’s how it played out over 72 weeks:
Tirzepatide (Zepbound) vs
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
